Watch this presentation by Advanced Instruments to see data for optimising choices of which combinations of GMP-compatible matrix, dissociation reagents and media can best be employed for single cell cloning of iPSCs in process development. We also discuss some of the vendor and instrumentation considerations in planning for the subsequent translation of the process into manufacturing.




Dr. Ian Taylor, Director of Business Development, Advanced Instruments, Solentim

Ian Taylor obtained a First Class Degree and PhD in Biochemistry from the University of Southampton. From University, Ian completed a formal business and accountancy training at KPMG.

Ian has more than 30 years working in the conceptualisation and commercialisation of novel high value life-sciences instrumentation, some of which have gone on to make significant contributions in the development of successful new biologics. Ian has been with Solentim since it was founded in 2010. Prior to that, he was part of the senior leadership team for PerkinElmer Life Sciences and Chief Commercial Officer at Genetix PLC.

In Ian’s new role with Advanced Instruments he will be largely focussing on technologies for gene therapy and cell therapy.

Camilla Domeneghetti, Laboratory Manager, Advanced Instruments, Solentim

Camilla Domeneghetti has the position of Laboratory Manager at Solentim, Advanced Instruments. Camilla started at Solentim in January 2019 and prior to this completed a Master’s of Research in Molecular Biology and an undergraduate degree in Biological Sciences. Her role includes overseeing the validation and optimisation of technologies to support the cell line development workflows. She has experience in cell culture and the optimisation of single cell seeding through to clone selection.

Please complete the form below and we’ll instantly send you an email with a link to the presentation:

Please double-check your ‘junk’ folder for the email from our [email protected] address.

Yes, I’m OK with this